Back to Overview

Durlip™ Unlock the Full Potential of Your Ingredients

Nov 05,2025

Summary: In the competitive landscape of dietary supplements and functional ingredients, bioavailability remains a critical challenge. Addressing this, INNOBIO introduces Durlip™, its premium line of liposomal solutions designed to maximize the efficacy of active compounds through precision delivery.
Summary:

多行文本内容元素

富文本内容绑定数据后可解析HTML语言内容

Durlip™ Unlock the Full Potential of Your Ingredients

In the competitive landscape of dietary supplements and functional ingredients, bioavailability remains a critical challenge. Addressing this, INNOBIO introduces Durlip™, its premium line of liposomal solutions designed to maximize the efficacy of active compounds through precision delivery.

What is Durlip™?

Durlip™ utilizes a liposomal structure to encapsulate active ingredients, shielding them from degradation and enhancing their absorption. Mimicking the body’s own cell membranes, this innovative technology ensures that nutrients are delivered more efficiently to where they are needed most.

A Diverse Portfolio for Enhanced Formulations

The Durlip™ range includes a variety of high-performance liposomal ingredients:
Liposomal Ascorbic Acid 70%
Liposomal β-NAD+ 50%
Liposomal Silybin 30%
Liposomal Ferric Pyrophosphate
Liposomal Zinc Bisglycinate
Liposomal Tricalcium Phosphate
Liposomal Magnesium Bisglycinate / Magnesium Oxide
Liposomal Glutathione
These products offer multiple advantages: Enhanced Stability, Improved Dispersion, Superior Structural Integrity, Enhanced Palatability, Gentle on the Stomach, and Optimized Bioavailability.

Proven Efficacy: Science-Backed Results

Substantial research underscores the effectiveness of Durlip™:
Guinea Pig Pharmacokinetic Study: A study administering 150 mg Vitamin C per kg body weight demonstrated that Durlip™ Liposomal VC achieved an AUC0-12 and a Cmax that were 388% and 441%, respectively, of those achieved by non-liposomal Vitamin C. This confirms a dramatic increase in both overall bioavailability and peak plasma concentration.
Caco-2 Cell Model Study: In vitro studies simulating human intestinal absorption showed that Durlip™ Liposomal Zinc resulted in a 16.8-fold increase in cellular uptake compared to non-liposomal zinc bisglycinate, highlighting its superior permeability and potential for enhanced efficacy in human applications.

Unlocking Ingredient Potential

"With Durlip™, we are not just offering another ingredient; we are offering a smarter delivery system," said a representative from INNOBIO. "Our technology ensures that premium actives realize their full potential, providing formulators with a clear, scientifically-validated advantage in creating more effective products."

Global Reach, Local Support

INNOBIO supports its partners worldwide through its offices in China, Europe, and the USA, providing access to cutting-edge liposomal solutions and technical expertise.

PREVIOUS:

Related Information

General Request

+86
  • +86 CN
SUBMIT

Take Appointment

+86
  • +86 CN
Submit